PagerDuty, Inc. (PD) is a publicly traded Technology sector company. As of May 21, 2026, PD trades at $7.07 with a market cap of $532.71M and a P/E ratio of 3.68. PD moved +3.63% today. Year to date, PD is -40.88%; over the trailing twelve months it is -55.99%. Its 52-week range spans $5.70 to $21.98. Analyst consensus is neutral with an average price target of $7.83. Rallies surfaces PD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading PD stock inside the company?
Recent PD insider activity includes Tejada Jennifer sold 105.10K, Tejada Jennifer sold 358.40K, Solomon Dan Alexandru sold 266.67K, Solomon Dan Alexandru sold 48, and Tejada Jennifer sold 1.57K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
PD Key Metrics
Key financial metrics for PD
Metric
Value
Price
$7.07
Market Cap
$532.71M
P/E Ratio
3.68
EPS
$1.91
Dividend Yield
0.20%
52-Week High
$21.98
52-Week Low
$5.70
Volume
56
Avg Volume
0
Revenue (TTM)
$492.55M
Net Income
$172.71M
Gross Margin
84.95%
Recent PD Insider Trades
Tejada Jennifer sold 105.10K (~$727.30K) on May 19, 2026.
Tejada Jennifer sold 358.40K (~$2.50M) on May 18, 2026.
Solomon Dan Alexandru sold 266.67K (~$3.56M) on Dec 30, 2025.
Solomon Dan Alexandru sold 48 (~$864) on Jul 25, 2025.
Tejada Jennifer sold 1.57K (~$31.38K) on Jan 28, 2025.
Recent PD insider activity includes Tejada Jennifer sold 105.10K, Tejada Jennifer sold 358.40K, Solomon Dan Alexandru sold 266.67K, Solomon Dan Alexandru sold 48, and Tejada Jennifer sold 1.57K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PD?
Yes. Rallies tracks PD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PD. It does not provide personalized investment advice.